JAFRA DAILY

Manufacturer: JAFRA COSMETICS INTERNATIONAL
Effective date: 2012-05-01
Label type: HUMAN OTC DRUG LABEL
Version: 1
Source: full-release
Hydrated at: 2026-05-31 22:31:37

Label at a glance#

ProductJAFRA DAILY FLORAL MIST FOR WOMEN

Active ingredientALUMINUM ZIRCONIUM TETRACHLOROHYDREX GLY

Label structure10 sections

Label contents#

Full prescribing information#

OTC - ACTIVE INGREDIENT SECTION

ACTIVE INGREDIENT
ALUMINUM ZIRCONIUM
TETRACHLOROHYDRATE
GLYCINE COMPLEX 15%

OTC - PURPOSE SECTION

PURPOSE

ANTIPERSPIRANT

INACTIVE INGREDIENT SECTION

INACTIVE INGREDIENTS: WATER/AQUA, CYCLOMETHICONE, PPG-15 STEARYL ETHER, STEARETH-2, CETETH-20, FARNESOL, AVENA SATIVA (OAT) KERNEL EXTRACT, FRAGRANCE/PARFUM, ISOPROPYL PALMITATE, TRICONTANYL PVP, BUTYLENE GLYCOL, PHENOXYETHANOL, METHYLPARABEN, ETHYLPARABEN, PROPYLPARABEN, BUTYLPARABEN.

INDICATIONS & USAGE SECTION

USES

REDUCES UNDERARM WETNESS

DOSAGE & ADMINISTRATION SECTION

DIRECTIONS

APPLY TO UNDERARMS ONLY

WARNINGS SECTION

WARNINGS

DO NOT USE ON BROKEN SKIN.

OTC - STOP USE SECTION

STOP USE IF RASH OR IRRITATION OCCURS.

OTC - KEEP OUT OF REACH OF CHILDREN SECTION

KEEP OUT OF REACH OF CHILDREN.

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

JAFRA

DAILY
FLORAL MIST
FOR WOMEN
ANTIPERSPIRANT
DEODORANT ROLL-ON

60 G / NET WT 2 OZ

OTC - ASK DOCTOR SECTION

ASK A DOCTOR BEFORE USE IF YOU HAVE KIDNEY DISEASE.

FDA-Initiated Inactive NDC Indexing#

NDC, Effective, Action table
NDC	Effective	Action	Document	Indexing SPL	Related label
68828-052-52	2020-01-31	C162847	48780-1	9d75b9d0-8a52-f424-e053-dadaa90a57ce	JAFRA DAILY FLORAL MIST

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDC	Product	Description	Form	Quantity	Strength	SPL version
68828-052-32	JAFRA DAILYFLORAL MIST FOR WOMEN	60 g in 1 BOTTLE	LOTION	60		1
68828-052-52	JAFRA DAILYFLORAL MIST FOR WOMEN	1 in 1 BOX	LOTION	1		1

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDC	Dashboard title	SPL version	Validation	Dashboard ZIP
68828-052	JAFRA DAILY FLORAL MIST FOR WOMEN (ALUMINUM ZIRCONIUM TETRACHLOROHYDREX GLY) LOTION [JAFRA COSMETICS INTERNATIONAL]	1	Legacy NDC, 2 package rows	20120503_5a546f4f-6a73-47e0-8787-9898473ec98d.zip

DailyMed Socrata Ingredients#

Ingredient, Type, UNII table
Ingredient	Type	UNII	SPL version
ALUMINUM ZIRCONIUM TETRACHLOROHYDREX GLY	ACTIVE INGREDIENT	8O386558JE	1
ALUMINUM CATION	ACTIVE MOIETY	3XHB1D032B	1
BUTYLENE GLYCOL	INACTIVE INGREDIENT	3XUS85K0RA	1
BUTYLPARABEN	INACTIVE INGREDIENT	3QPI1U3FV8	1
CETETH-20	INACTIVE INGREDIENT	I835H2IHHX	1
CYCLOMETHICONE	INACTIVE INGREDIENT	NMQ347994Z	1
ETHYLPARABEN	INACTIVE INGREDIENT	14255EXE39	1
FARNESOL	INACTIVE INGREDIENT	EB41QIU6JL	1
ISOPROPYL PALMITATE	INACTIVE INGREDIENT	8CRQ2TH63M	1
METHYLPARABEN	INACTIVE INGREDIENT	A2I8C7HI9T	1
OAT	INACTIVE INGREDIENT	Z6J799EAJK	1
PHENOXYETHANOL	INACTIVE INGREDIENT	HIE492ZZ3T	1
POVIDONE K30	INACTIVE INGREDIENT	U725QWY32X	1
PPG-15 STEARYL ETHER	INACTIVE INGREDIENT	1II18XLS1L	1
PROPYLPARABEN	INACTIVE INGREDIENT	Z8IX2SC1OH	1
SORBITAN SESQUIOLEATE	INACTIVE INGREDIENT	0W8RRI5W5A	1
STEARETH-2	INACTIVE INGREDIENT	V56DFE46J5	1
WATER	INACTIVE INGREDIENT	059QF0KO0R	1

Products#

Every source-derived product name is available through these pages.

DailyMed product names page 1 of 1 · 19 matching rows.

JAFRA DAILY FLORAL MIST FOR WOMEN
ALUMINUM ZIRCONIUM TETRACHLOROHYDREX GLY
ALUMINUM CATION
WATER
CYCLOMETHICONE
PPG-15 STEARYL ETHER
STEARETH-2
SORBITAN SESQUIOLEATE
CETETH-20
FARNESOL
OAT
ISOPROPYL PALMITATE
POVIDONE K30
BUTYLENE GLYCOL
PHENOXYETHANOL
METHYLPARABEN
ETHYLPARABEN
PROPYLPARABEN
BUTYLPARABEN

NDC Codes#

Product NDC, Package NDC table
Product NDC	Package NDC
68828-052	68828-052-32, 68828-052-52

Ingredients#

Every source-derived ingredient row is available through these pages.

DailyMed ingredient rows page 1 of 1 · 17 matching rows.

Name, UNII, Kind table
Name	UNII	Kind
ALUMINUM ZIRCONIUM TETRACHLOROHYDREX GLY	8O386558JE	ACTIB
WATER	059QF0KO0R	IACT
CYCLOMETHICONE	NMQ347994Z	IACT
PPG-15 STEARYL ETHER	1II18XLS1L	IACT
STEARETH-2	V56DFE46J5	IACT
SORBITAN SESQUIOLEATE	0W8RRI5W5A	IACT
CETETH-20	I835H2IHHX	IACT
FARNESOL	EB41QIU6JL	IACT
OAT	Z6J799EAJK	IACT
ISOPROPYL PALMITATE	8CRQ2TH63M	IACT
POVIDONE K30	U725QWY32X	IACT
BUTYLENE GLYCOL	3XUS85K0RA	IACT
PHENOXYETHANOL	HIE492ZZ3T	IACT
METHYLPARABEN	A2I8C7HI9T	IACT
ETHYLPARABEN	14255EXE39	IACT
PROPYLPARABEN	Z8IX2SC1OH	IACT
BUTYLPARABEN	3QPI1U3FV8	IACT

Source Document#

Source XML

Inactive ingredient matches#

Inactive Ingredient Database values describe FDA-listed use contexts. The match method and ambiguity count are shown because ingredient names, routes, and dosage forms are not always unique. Browse recovered IID releases and source provenance.

Inactive ingredient links page 1 of 4 · 240 matching rows.

DailyMed ingredient, IID ingredient, UNII table
DailyMed ingredient	IID ingredient	UNII	Dosage form / route	Potency	Maximum daily exposure	Match
CETETH-20	CETETH-20	I835H2IHHX	CREAM / TOPICAL		571 mg	Exact identifier — unii candidate 4 equally ranked IID candidates
CYCLOMETHICONE	CYCLOMETHICONE	NMQ347994Z	CREAM / TOPICAL		358 mg	Exact identifier — unii candidate 5 equally ranked IID candidates
METHYLPARABEN	METHYLPARABEN	A2I8C7HI9T	SHAMPOO / TOPICAL	0.15 %w/w		Exact identifier — unii candidate 79 equally ranked IID candidates
PROPYLPARABEN	PROPYLPARABEN	Z8IX2SC1OH	INJECTION / INTRAVENOUS		6 mg	Exact identifier — unii candidate 68 equally ranked IID candidates
METHYLPARABEN	METHYLPARABEN	A2I8C7HI9T	GEL / VAGINAL		8 mg	Exact identifier — unii candidate 79 equally ranked IID candidates
METHYLPARABEN	METHYLPARABEN	A2I8C7HI9T	DROPS / NASAL	26 mg		Exact identifier — unii candidate 79 equally ranked IID candidates
PROPYLPARABEN	PROPYLPARABEN	Z8IX2SC1OH	SYSTEM / TOPICAL		21 mg	Exact identifier — unii candidate 68 equally ranked IID candidates
POVIDONE K30	POVIDONE K30	U725QWY32X	SOLUTION / ORAL		300 mg	Exact identifier — unii candidate 40 equally ranked IID candidates
PROPYLPARABEN	PROPYLPARABEN	Z8IX2SC1OH	ENEMA / RECTAL	0.02 %w/w		Exact identifier — unii candidate 68 equally ranked IID candidates
METHYLPARABEN	METHYLPARABEN	A2I8C7HI9T	ENEMA / RECTAL	0.18 %w/v		Exact identifier — unii candidate 79 equally ranked IID candidates
PROPYLPARABEN	PROPYLPARABEN	Z8IX2SC1OH	SOLUTION / OPHTHALMIC	0.02 %w/w		Exact identifier — unii candidate 68 equally ranked IID candidates
ISOPROPYL PALMITATE	ISOPROPYL PALMITATE	8CRQ2TH63M	FILM, EXTENDED RELEASE / TRANSDERMAL	187.5 mg		Exact identifier — unii candidate 8 equally ranked IID candidates
POVIDONE K30	POVIDONE K30	U725QWY32X	PELLET / ORAL		24 mg	Exact identifier — unii candidate 40 equally ranked IID candidates
POVIDONE K30	POVIDONE K30	U725QWY32X	CAPSULE, COATED, EXTENDED RELEASE / ORAL		15 mg	Exact identifier — unii candidate 40 equally ranked IID candidates
PROPYLPARABEN	PROPYLPARABEN	Z8IX2SC1OH	SYRUP / ORAL		40 mg	Exact identifier — unii candidate 68 equally ranked IID candidates
PROPYLPARABEN	PROPYLPARABEN	Z8IX2SC1OH	EMULSION / TOPICAL	0.06 %w/w		Exact identifier — unii candidate 68 equally ranked IID candidates
METHYLPARABEN	METHYLPARABEN	A2I8C7HI9T	CREAM / TOPICAL		3000 mg	Exact identifier — unii candidate 79 equally ranked IID candidates
POVIDONE K30	POVIDONE K30	U725QWY32X	CAPSULE, DELAYED RELEASE PELLETS / ORAL		178 mg	Exact identifier — unii candidate 40 equally ranked IID candidates
ISOPROPYL PALMITATE	ISOPROPYL PALMITATE	8CRQ2TH63M	GEL / TOPICAL	NA		Exact identifier — unii candidate 8 equally ranked IID candidates
POVIDONE K30	POVIDONE K30	U725QWY32X	CAPSULE, LIQUID FILLED / ORAL		101 mg	Exact identifier — unii candidate 40 equally ranked IID candidates
METHYLPARABEN	METHYLPARABEN	A2I8C7HI9T	SOLUTION / INTRAVENOUS	0.13 %w/v		Exact identifier — unii candidate 79 equally ranked IID candidates
PROPYLPARABEN	PROPYLPARABEN	Z8IX2SC1OH	SOLUTION / RECTAL	0.02 %w/v		Exact identifier — unii candidate 68 equally ranked IID candidates
METHYLPARABEN	METHYLPARABEN	A2I8C7HI9T	DROPS / AURICULAR (OTIC)	0.01 %w/w		Exact identifier — unii candidate 79 equally ranked IID candidates
PHENOXYETHANOL	PHENOXYETHANOL	HIE492ZZ3T	AEROSOL / TOPICAL	1.05 %w/w		Exact identifier — unii candidate 6 equally ranked IID candidates
METHYLPARABEN	METHYLPARABEN	A2I8C7HI9T	TABLET, CHEWABLE / ORAL	1.28 mg		Exact identifier — unii candidate 79 equally ranked IID candidates
POVIDONE K30	POVIDONE K30	U725QWY32X	SUSPENSION / OPHTHALMIC		14 mg	Exact identifier — unii candidate 40 equally ranked IID candidates
BUTYLPARABEN	BUTYLPARABEN	3QPI1U3FV8	CREAM / TOPICAL	0.4 %w/w		Exact identifier — unii candidate 15 equally ranked IID candidates
METHYLPARABEN	METHYLPARABEN	A2I8C7HI9T	CREAM / VAGINAL		22 mg	Exact identifier — unii candidate 79 equally ranked IID candidates
ETHYLPARABEN	ETHYLPARABEN	14255EXE39	SOLUTION / ORAL		14 mg	Exact identifier — unii candidate 4 equally ranked IID candidates
POVIDONE K30	POVIDONE K30	U725QWY32X	SUSPENSION / ORAL		148 mg	Exact identifier — unii candidate 40 equally ranked IID candidates
PROPYLPARABEN	PROPYLPARABEN	Z8IX2SC1OH	INJECTION / INTRA-ARTICULAR	0.03 %w/v		Exact identifier — unii candidate 68 equally ranked IID candidates
METHYLPARABEN	METHYLPARABEN	A2I8C7HI9T	INJECTION / INTRALESIONAL	0.15 %w/v		Exact identifier — unii candidate 79 equally ranked IID candidates
BUTYLPARABEN	BUTYLPARABEN	3QPI1U3FV8	LIQUID / TOPICAL	0.02 %w/w		Exact identifier — unii candidate 15 equally ranked IID candidates
METHYLPARABEN	METHYLPARABEN	A2I8C7HI9T	INJECTION / EPIDURAL	1 mg		Exact identifier — unii candidate 79 equally ranked IID candidates
POVIDONE K30	POVIDONE K30	U725QWY32X	TABLET, EXTENDED RELEASE / ORAL		368 mg	Exact identifier — unii candidate 40 equally ranked IID candidates
PROPYLPARABEN	PROPYLPARABEN	Z8IX2SC1OH	SOLUTION/ DROPS / OPHTHALMIC	0.01 %w/v		Exact identifier — unii candidate 68 equally ranked IID candidates
PROPYLPARABEN	PROPYLPARABEN	Z8IX2SC1OH	SPRAY / TOPICAL	0.8 %w/w		Exact identifier — unii candidate 68 equally ranked IID candidates
POVIDONE K30	POVIDONE K30	U725QWY32X	TABLET, FOR SUSPENSION / ORAL		462 mg	Exact identifier — unii candidate 40 equally ranked IID candidates
METHYLPARABEN	METHYLPARABEN	A2I8C7HI9T	TABLET, EXTENDED RELEASE / ORAL	0.17 mg		Exact identifier — unii candidate 79 equally ranked IID candidates
METHYLPARABEN	METHYLPARABEN	A2I8C7HI9T	DROPS / OPHTHALMIC	0.01 %w/w		Exact identifier — unii candidate 79 equally ranked IID candidates
PROPYLPARABEN	PROPYLPARABEN	Z8IX2SC1OH	CONCENTRATE / ORAL	2.5 mg/5ml		Exact identifier — unii candidate 68 equally ranked IID candidates
POVIDONE K30	POVIDONE K30	U725QWY32X	TABLET, CHEWABLE, EXTENDED RELEASE / ORAL		12 mg	Exact identifier — unii candidate 40 equally ranked IID candidates
ISOPROPYL PALMITATE	ISOPROPYL PALMITATE	8CRQ2TH63M	LOTION / TOPICAL	5 %w/w		Exact identifier — unii candidate 8 equally ranked IID candidates
BUTYLENE GLYCOL	BUTYLENE GLYCOL	3XUS85K0RA	SYSTEM / TOPICAL		1400 mg	Exact identifier — unii candidate 2 equally ranked IID candidates
PROPYLPARABEN	PROPYLPARABEN	Z8IX2SC1OH	CREAM / VAGINAL		3 mg	Exact identifier — unii candidate 68 equally ranked IID candidates
ISOPROPYL PALMITATE	ISOPROPYL PALMITATE	8CRQ2TH63M	FILM / TRANSDERMAL		2 mg	Exact identifier — unii candidate 8 equally ranked IID candidates
PROPYLPARABEN	PROPYLPARABEN	Z8IX2SC1OH	INJECTION / SOFT TISSUE	0.02 %w/v		Exact identifier — unii candidate 68 equally ranked IID candidates
METHYLPARABEN	METHYLPARABEN	A2I8C7HI9T	AEROSOL, FOAM / VAGINAL	0.1 %w/w		Exact identifier — unii candidate 79 equally ranked IID candidates
METHYLPARABEN	METHYLPARABEN	A2I8C7HI9T	SOLUTION / RECTAL	0.13 %w/v		Exact identifier — unii candidate 79 equally ranked IID candidates
PROPYLPARABEN	PROPYLPARABEN	Z8IX2SC1OH	INJECTION, POWDER, FOR SOLUTION / INTRAVENOUS	0.8 mg		Exact identifier — unii candidate 68 equally ranked IID candidates
PPG-15 STEARYL ETHER	POLYPROPYLENE GLYCOL 15 STEARYL ETHER	1II18XLS1L	SUSPENSION / TOPICAL		2288 mg	Exact identifier — unii candidate 3 equally ranked IID candidates
METHYLPARABEN	METHYLPARABEN	A2I8C7HI9T	SUSPENSION / SUBCUTANEOUS	0.16 %w/v		Exact identifier — unii candidate 79 equally ranked IID candidates
PROPYLPARABEN	PROPYLPARABEN	Z8IX2SC1OH	SUSPENSION / ORAL		64 mg	Exact identifier — unii candidate 68 equally ranked IID candidates
METHYLPARABEN	METHYLPARABEN	A2I8C7HI9T	ELIXIR / ORAL	800 mg		Exact identifier — unii candidate 79 equally ranked IID candidates
ISOPROPYL PALMITATE	ISOPROPYL PALMITATE	8CRQ2TH63M	AEROSOL, SPRAY / TOPICAL		397 mg	Exact identifier — unii candidate 8 equally ranked IID candidates
METHYLPARABEN	METHYLPARABEN	A2I8C7HI9T	SOLUTION / ORAL		346 mg	Exact identifier — unii candidate 79 equally ranked IID candidates
METHYLPARABEN	METHYLPARABEN	A2I8C7HI9T	SYSTEM / TOPICAL		42 mg	Exact identifier — unii candidate 79 equally ranked IID candidates
PROPYLPARABEN	PROPYLPARABEN	Z8IX2SC1OH	SUSPENSION / AURICULAR (OTIC)	NA		Exact identifier — unii candidate 68 equally ranked IID candidates
PROPYLPARABEN	PROPYLPARABEN	Z8IX2SC1OH	TABLET, CHEWABLE / ORAL	0.14 mg		Exact identifier — unii candidate 68 equally ranked IID candidates
BUTYLPARABEN	BUTYLPARABEN	3QPI1U3FV8	DROPS / ORAL	NA		Exact identifier — unii candidate 15 equally ranked IID candidates

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
Brand	Generic	Manufacturer	SPL set ID	Effective date	Available safety fields	Join
5f535b60-24e3-4113-937e-52a381023a91			5a546f4f-6a73-47e0-8787-9898473ec98d	2012-05-01	Warnings	Exact identifier spl id: 5f535b60-24e3-4113-937e-52a381023a91 spl set id: 5a546f4f-6a73-47e0-8787-9898473ec98d

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.